Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $746.51 | 28 | 98.4% |
| Education | $12.50 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $587.00 | 25 | $0 (2020) |
| GlaxoSmithKline, LLC. | $88.08 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $39.54 | 2 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $23.72 | 1 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $20.67 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $36.47 | 1 | Janssen Pharmaceuticals, Inc ($36.47) |
| 2019 | $346.50 | 10 | Janssen Pharmaceuticals, Inc ($262.57) |
| 2018 | $309.51 | 15 | Janssen Pharmaceuticals, Inc ($221.43) |
| 2017 | $66.53 | 4 | Janssen Pharmaceuticals, Inc ($66.53) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $108.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Respiratory | ||||||
| 10/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/23/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Respiratory | ||||||
| 06/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $91.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/15/2019 | Sun Pharmaceutical Industries Inc. | KAPSPARGO (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $6.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $6.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $88.08 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 524 | 3,368 | $487,051 | $241,323 |
| 2022 | 3 | 808 | 4,814 | $702,890 | $318,843 |
| 2021 | 5 | 733 | 4,358 | $638,196 | $298,954 |
| 2020 | 7 | 798 | 4,420 | $649,909 | $305,988 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 153 | 1,828 | $250,652 | $122,377 | 48.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 85 | 1,192 | $163,304 | $77,808 | 47.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 126 | 155 | $37,975 | $18,081 | 47.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 122 | 154 | $26,564 | $18,069 | 68.0% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 23 | 23 | $5,839 | $3,133 | 53.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2023 | 15 | 16 | $2,717 | $1,853 | 68.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 247 | 2,786 | $382,978 | $171,438 | 44.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 103 | 1,455 | $199,443 | $87,823 | 44.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 233 | 299 | $73,255 | $34,408 | 47.0% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 194 | 239 | $41,194 | $22,084 | 53.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2022 | 31 | 35 | $6,020 | $3,090 | 51.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 227 | 2,709 | $371,673 | $169,683 | 45.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 89 | 1,123 | $153,959 | $71,892 | 46.7% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 199 | 265 | $64,817 | $31,675 | 48.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 144 | 184 | $31,613 | $17,819 | 56.4% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 28 | 28 | $7,420 | $3,517 | 47.4% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2021 | 24 | 27 | $4,644 | $2,421 | 52.1% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2021 | 22 | 22 | $4,070 | $1,947 | 47.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 202 | 2,377 | $326,189 | $153,258 | 47.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 95 | 1,455 | $199,335 | $90,848 | 45.6% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 158 | 198 | $48,510 | $23,867 | 49.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2020 | 125 | 149 | $25,628 | $14,642 | 57.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 89 | $19,936 | $8,209 | 41.2% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2020 | 59 | 59 | $10,915 | $5,273 | 48.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 33 | 35 | $9,019 | $4,386 | 48.6% |
About Dr. Richard Moskowitz, MD
Dr. Richard Moskowitz, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124102868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Moskowitz, MD has received a total of $759.01 in payments from pharmaceutical and medical device companies, with $36.47 received in 2020. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($746.51).
As a Medicare-enrolled provider, Moskowitz has provided services to 2,863 Medicare beneficiaries, totaling 16,960 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 10/25/2006
- Last Updated 10/06/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124102868
Products in Payments
- XARELTO (Drug) $478.25
- INVOKANA (Drug) $108.75
- TRELEGY ELLIPTA (Drug) $88.08
- SYMBICORT (Drug) $39.54
- KAPSPARGO (Drug) $23.72
- NUEDEXTA (Drug) $20.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620